Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Use this CPRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CPRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CPRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Catalyst Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CPRX income, balance, and cash tables.